Impact of Medicare Part D on mental health treatment and outcomes for dual eligible beneficiaries with HIV

Nadya Belenky, Brian W. Pence, Stephen R. Cole, Stacie B. Dusetzina, Andrew Edmonds, Jonathan Oberlander, Michael Plankey, Adebola A. Adedimeji, Tracey E. Wilson, Jennifer Cohen, Mardge H. Cohen, Joel E. Milam, Adaora A. Adimora

Research output: Contribution to journalArticle

Abstract

Depression is common among women with HIV and untreated depression can result in poor quality of life and worsen HIV outcomes. Women with HIV who are dually enrolled in Medicaid and Medicare faced a potential disruption in medication access when Medicare Part D was implemented in 2006. The goal of this study was to estimate the effects of Medicare Part D implementation on antidepressant use, depressive symptoms, and hospitalization in Medicaid-Medicare dual eligible women with HIV. This study used 2003–2008 data from the Women's Interagency HIV Study. The effects of Medicare Part D were estimated using a difference-in-differences approach, adjusting for temporal trends using a matched control group of Medicaid-only enrollees. Before Medicare Part D implementation, dual eligibles differed from Medicaid-only enrollees in antidepressant use and hospitalization, despite having identical prescription drug coverage through Medicaid. For dual enrollees, the transition to Medicare Part D was not associated with changes in antidepressant use, depressive symptoms, or hospitalization. We did not find disruptive effects on antidepressant use and related outcomes among dual eligibles in this study. Stable antidepressant use may be due to better access to medical care for dual eligibles through Medicare both before and after Medicare Part D implementation, which may have eclipsed any effects of the transition. It may also signal that classification of antidepressants as a protected drug class under Medicare Part D was effective in preventing psychiatric medication disruption.

Original languageEnglish (US)
JournalAIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Medicare Part D
Mental Health
Antidepressive Agents
Medicaid
mental health
hospitalization
HIV
medication
Medicare
Depression
Hospitalization
drug
medical care
quality of life
coverage
Prescription Drugs
trend
Psychiatry
Research Design
Quality of Life

Keywords

  • HIV
  • Medicare Part D
  • mental health

ASJC Scopus subject areas

  • Health(social science)
  • Social Psychology
  • Public Health, Environmental and Occupational Health

Cite this

Impact of Medicare Part D on mental health treatment and outcomes for dual eligible beneficiaries with HIV. / Belenky, Nadya; Pence, Brian W.; Cole, Stephen R.; Dusetzina, Stacie B.; Edmonds, Andrew; Oberlander, Jonathan; Plankey, Michael; Adedimeji, Adebola A.; Wilson, Tracey E.; Cohen, Jennifer; Cohen, Mardge H.; Milam, Joel E.; Adimora, Adaora A.

In: AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV, 01.01.2018.

Research output: Contribution to journalArticle

Belenky, N, Pence, BW, Cole, SR, Dusetzina, SB, Edmonds, A, Oberlander, J, Plankey, M, Adedimeji, AA, Wilson, TE, Cohen, J, Cohen, MH, Milam, JE & Adimora, AA 2018, 'Impact of Medicare Part D on mental health treatment and outcomes for dual eligible beneficiaries with HIV', AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV. https://doi.org/10.1080/09540121.2018.1516283
Belenky, Nadya ; Pence, Brian W. ; Cole, Stephen R. ; Dusetzina, Stacie B. ; Edmonds, Andrew ; Oberlander, Jonathan ; Plankey, Michael ; Adedimeji, Adebola A. ; Wilson, Tracey E. ; Cohen, Jennifer ; Cohen, Mardge H. ; Milam, Joel E. ; Adimora, Adaora A. / Impact of Medicare Part D on mental health treatment and outcomes for dual eligible beneficiaries with HIV. In: AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV. 2018.
@article{4321a25624c942e9a11f7e540ee004be,
title = "Impact of Medicare Part D on mental health treatment and outcomes for dual eligible beneficiaries with HIV",
abstract = "Depression is common among women with HIV and untreated depression can result in poor quality of life and worsen HIV outcomes. Women with HIV who are dually enrolled in Medicaid and Medicare faced a potential disruption in medication access when Medicare Part D was implemented in 2006. The goal of this study was to estimate the effects of Medicare Part D implementation on antidepressant use, depressive symptoms, and hospitalization in Medicaid-Medicare dual eligible women with HIV. This study used 2003–2008 data from the Women's Interagency HIV Study. The effects of Medicare Part D were estimated using a difference-in-differences approach, adjusting for temporal trends using a matched control group of Medicaid-only enrollees. Before Medicare Part D implementation, dual eligibles differed from Medicaid-only enrollees in antidepressant use and hospitalization, despite having identical prescription drug coverage through Medicaid. For dual enrollees, the transition to Medicare Part D was not associated with changes in antidepressant use, depressive symptoms, or hospitalization. We did not find disruptive effects on antidepressant use and related outcomes among dual eligibles in this study. Stable antidepressant use may be due to better access to medical care for dual eligibles through Medicare both before and after Medicare Part D implementation, which may have eclipsed any effects of the transition. It may also signal that classification of antidepressants as a protected drug class under Medicare Part D was effective in preventing psychiatric medication disruption.",
keywords = "HIV, Medicare Part D, mental health",
author = "Nadya Belenky and Pence, {Brian W.} and Cole, {Stephen R.} and Dusetzina, {Stacie B.} and Andrew Edmonds and Jonathan Oberlander and Michael Plankey and Adedimeji, {Adebola A.} and Wilson, {Tracey E.} and Jennifer Cohen and Cohen, {Mardge H.} and Milam, {Joel E.} and Adimora, {Adaora A.}",
year = "2018",
month = "1",
day = "1",
doi = "10.1080/09540121.2018.1516283",
language = "English (US)",
journal = "AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV",
issn = "0954-0121",
publisher = "Routledge",

}

TY - JOUR

T1 - Impact of Medicare Part D on mental health treatment and outcomes for dual eligible beneficiaries with HIV

AU - Belenky, Nadya

AU - Pence, Brian W.

AU - Cole, Stephen R.

AU - Dusetzina, Stacie B.

AU - Edmonds, Andrew

AU - Oberlander, Jonathan

AU - Plankey, Michael

AU - Adedimeji, Adebola A.

AU - Wilson, Tracey E.

AU - Cohen, Jennifer

AU - Cohen, Mardge H.

AU - Milam, Joel E.

AU - Adimora, Adaora A.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Depression is common among women with HIV and untreated depression can result in poor quality of life and worsen HIV outcomes. Women with HIV who are dually enrolled in Medicaid and Medicare faced a potential disruption in medication access when Medicare Part D was implemented in 2006. The goal of this study was to estimate the effects of Medicare Part D implementation on antidepressant use, depressive symptoms, and hospitalization in Medicaid-Medicare dual eligible women with HIV. This study used 2003–2008 data from the Women's Interagency HIV Study. The effects of Medicare Part D were estimated using a difference-in-differences approach, adjusting for temporal trends using a matched control group of Medicaid-only enrollees. Before Medicare Part D implementation, dual eligibles differed from Medicaid-only enrollees in antidepressant use and hospitalization, despite having identical prescription drug coverage through Medicaid. For dual enrollees, the transition to Medicare Part D was not associated with changes in antidepressant use, depressive symptoms, or hospitalization. We did not find disruptive effects on antidepressant use and related outcomes among dual eligibles in this study. Stable antidepressant use may be due to better access to medical care for dual eligibles through Medicare both before and after Medicare Part D implementation, which may have eclipsed any effects of the transition. It may also signal that classification of antidepressants as a protected drug class under Medicare Part D was effective in preventing psychiatric medication disruption.

AB - Depression is common among women with HIV and untreated depression can result in poor quality of life and worsen HIV outcomes. Women with HIV who are dually enrolled in Medicaid and Medicare faced a potential disruption in medication access when Medicare Part D was implemented in 2006. The goal of this study was to estimate the effects of Medicare Part D implementation on antidepressant use, depressive symptoms, and hospitalization in Medicaid-Medicare dual eligible women with HIV. This study used 2003–2008 data from the Women's Interagency HIV Study. The effects of Medicare Part D were estimated using a difference-in-differences approach, adjusting for temporal trends using a matched control group of Medicaid-only enrollees. Before Medicare Part D implementation, dual eligibles differed from Medicaid-only enrollees in antidepressant use and hospitalization, despite having identical prescription drug coverage through Medicaid. For dual enrollees, the transition to Medicare Part D was not associated with changes in antidepressant use, depressive symptoms, or hospitalization. We did not find disruptive effects on antidepressant use and related outcomes among dual eligibles in this study. Stable antidepressant use may be due to better access to medical care for dual eligibles through Medicare both before and after Medicare Part D implementation, which may have eclipsed any effects of the transition. It may also signal that classification of antidepressants as a protected drug class under Medicare Part D was effective in preventing psychiatric medication disruption.

KW - HIV

KW - Medicare Part D

KW - mental health

UR - http://www.scopus.com/inward/record.url?scp=85053454331&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85053454331&partnerID=8YFLogxK

U2 - 10.1080/09540121.2018.1516283

DO - 10.1080/09540121.2018.1516283

M3 - Article

C2 - 30189747

AN - SCOPUS:85053454331

JO - AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

JF - AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

SN - 0954-0121

ER -